Dose (mg/ml) | Effect | 1% DMSO | DA | RM-M | RM-H | Anemonin |
---|---|---|---|---|---|---|
4.0 | Change in motility (in min) | NE | 10a | 30b | 20a | 5a |
No of infectious mice / Total no of mice | 5/5 | 0/5 | 2/5 | 0/5 | 0/5 | |
Infection interval (in days) | 12 ± 0.00 | Ni | 18 ± 0.34 | Ni | Ni | |
2.0 | Change in motility (in min) | NE | 15b | 45b | 25b | 15b |
No of infectious mice / Total no of mice | 5/5 | 1/5 | 3/5 | 2/5 | 1/5 | |
Infection interval (in days) | 12 ± 0.00 | 22 | 16 ± 0.48 | 18 ± 0.50 | 22 | |
0.4 | Change in motility (in min) | NE | 30b | 50b | 45b | 20b |
No of infectious mice / Total no of mice | 5/5 | 3/5 | 5/5 | 4/5 | 2/5 | |
Infection interval (in days) | 12 ± 0.00 | 16 ± 0.56 | 12 ± 0.00 | 14 ± 0.37 | 18 ± 0.00 | |
0.1 | Change in motility (in min) | NE | 45b | NE | NE | 35b |
No of infectious mice / Total no of mice | 5/5 | 4/5 | 5/5 | 5/5 | 3/5 | |
Infection interval (in days) | 12 ± 0.00 | 14 ± 0.48 | 12 ± 0.00 | 12 ± 0.00 | 16 ± 0.37 |